Back to News
Top StoriesMarketWatch1d ago

Moderna’s cancer vaccine hits its targets, but a data leak rattles investors and the stock tumbles

A ‘sell-the-news reaction’? The experimental treatment helped prevent the return of cancer or death in melanoma patients by 42% after two years.

Read Full Article on MarketWatch

MENTIONED STOCKS

Content sourced from MarketWatch. Not financial advice.